RespireRx Pharmaceuticals Inc. (RSPI) has 20 known insider and institutional holders on record. The largest holder is ORIGIN VENTURES II LP with 24,200,507 shares. Other notable holders include IllinoisVentures GP, LLC and Jones Timothy L..
RSPI Insider Ownership
Top Holder
ORIGIN VENTURES II LP
24,200,507 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Origin Ventures Ii Lp |
10 Percent Owner |
24,200,507 |
2012-09-19 |
|
| 2 |
Illinoisventures Gp, Llc |
10 Percent Owner |
20,334,546 |
2012-08-20 |
|
| 3 |
Jones Timothy L. |
CEO and President |
17,000,000 |
2020-08-04 |
|
| 4 |
Purcell Richard David Jr. |
SVP - Research and Development |
5,000,000 |
2020-08-04 |
|
| 5 |
Macfarlane Katie |
Director |
5,000,000 |
2020-10-02 |
|
| 6 |
Samyang Optics Co., Ltd |
10 Percent Owner |
4,000,000 |
2012-06-27 |
|
| 7 |
Radin Marc M |
Controller |
4,000,000 |
2014-04-16 |
|
| 8 |
Stoll Roger G Phd |
Executive Chairman |
3,083,334 |
2012-08-14 |
|
| 9 |
T. Morgen Capital Llc |
Officer |
2,971,792 |
2013-04-01 |
|
| 10 |
Aurora Capital Llc |
Officer |
2,971,792 |
2013-04-01 |
|
| 11 |
Aurora Capital Corp |
Officer |
2,971,792 |
2013-04-01 |
|
| 12 |
Coleman James H |
Sr. VP, Business Development |
2,083,334 |
2012-08-14 |
|
| 13 |
Dickason David |
SVP of Pre-clinical Prod. Dev. |
2,000,000 |
2020-10-06 |
|
| 14 |
Carley David W. |
Director |
1,899,158 |
2012-08-20 |
|
| 15 |
Letendre Peter |
Director |
684,031 |
2012-08-20 |
|
| 16 |
Cohen Kenneth M |
Officer |
656,755 |
2013-04-01 |
|
| 17 |
Varney Mark A |
President and CEO |
588,000 |
2009-08-24 |
|
| 18 |
Messinger Maria S |
Chief Financial Officer |
380,000 |
2009-08-24 |
|
| 19 |
Chizzik Steven |
Officer |
330,199 |
2013-04-01 |
|
| 20 |
Johnson Steven Andrew |
VP, Preclinical Development |
262,000 |
2009-08-24 |
|
No ownership data available for RSPI.
